Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride
- 14 November 1995
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 286 (2), R3-R5
- https://doi.org/10.1016/0014-2999(95)00677-d
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Absence of detectable striatal dopamine D4 receptors in drug-treated schizophreniaEuropean Journal of Pharmacology, 1995
- Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depressionBrain Research, 1995
- Dopamine D4‐Like Receptor Elevation in Schizophrenia: Cloned D2 and D4 Receptors Cannot Be Discriminated by Raclopride Competition Against [3H]NemonaprideJournal of Neurochemistry, 1995
- Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophreniaJournal of Neuroscience, 1995
- Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?Journal of Neurochemistry, 1994
- Dopamine receptor pharmacologyTrends in Pharmacological Sciences, 1994
- Dopamine D4 receptors elevated in schizophreniaNature, 1993
- Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligandsEuropean Journal of Pharmacology, 1984